Thus, our finding of the missing influence of CXCR4 expression (and SDF-1 abundance) on patient outcome is in line with the above-mentioned fact that haematogenetic metastases to organs with high SDF-1 expression is relatively rare in ovarian cancer. This evidence concerns the gene CXCR4 and ovarian carcinoma.